Jaspan, Vita N.
Greenberg, Garred S.
Parihar, Siddhant
Park, Christine M.
Somers, Virend K.
Shapiro, Michael D.
Lavie, Carl J.
Virani, Salim S.
Slipczuk, Leandro
Article History
Accepted: 1 May 2024
First Online: 25 May 2024
Declarations
:
: Leandro Slipczuk is supported by institutional grants from Amgen and Philips. Salim Virani is supported by research grants from the NIH, UK NIHR, US Department of Veterans Affairs and research endowments from the Tahir and Jooma Family and Asharia Family. Additionally, Dr. Virani serves as a section editor for Current Atherosclerosis Reports. Michael D. Shapiro is supported by institutional grants from Amgen, Boehringer Ingelheim, 89Bio, Esperion, Genentech, Novartis, Ionis, Merck, and New Amsterdam. He has participated in Scientific Advisory Boards with Amgen, Agepha, Ionis, Novartis, New Amsterdam, and Merck. He has served as a consultant for Ionis, Novartis, Regeneron, Aidoc, Shanghai Pharma Biotherapeutics, Kaneka, and Novo Nordisk. Virend K Somers is supported by NIH HL65176 and NIH HL160619. He is a consultant for Jazz Pharma, Axsome, Know Labs, Lilly and ApniMed and serves on the Sleep Number Scientific Advisory Board. The remaining authors have nothing to disclose.
: No animal or human subjects were used by the authors in this study.